α5β1 integrin ligand PHSRN induces invasion and α5 mRNA in endothelial cells to stimulate angiogenesis

Translational Oncology

Volumn 2, Issue 1, 2009, Pages 8-20

  Zeng, Zhao Zhu ^a   Yao, Hongren ^a   Staszewski, Evan D ^a   Rockwood, Korrene F ^a   Markwart, Sonja M ^a   Fay, Kevin S ^a   Spalding, Aaron C ^a,c   Livant, Donna L ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA5 INTEGRIN; HSPNC PEPTIDE; INTERSTITIAL COLLAGENASE; LIGAND; MATRIGEL; MESSENGER RNA; PEPTIDE; PROLYLHISTIDYLSERYLARGINYLASPARAGINE; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VERY LATE ACTIVATION ANTIGEN 5;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL INVASION; CELL SURFACE; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; GENE INDUCTION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IN VIVO STUDY; MICROVASCULARIZATION; MOUSE; NONHUMAN; PROTEIN INTERACTION; UPREGULATION;

EID: 70449645644     PISSN: None     EISSN: 19365233     Source Type: Journal    
DOI: 10.1593/tlo.08187     Document Type: Article

References (54)

1. Livant DL, Brabec RK, Pienta KJ, Allen DL, Kurachi K, Markwart S, and Upadhyaya A (2000). Anti-invasive, antitumorigenic, and antimetastatic activities of the PHSCN sequence in prostate carcinoma. Cancer Res 60, 309-320.
2. Livant DL, Brabec RK, Kurachi K, Allen DL, Wu Y, Haaseth R, Andrews P, Ethier SP, and Markwart S (2000). The PHSRN sequence induces extracellular matrix invasion and accelerates wound healing in obese diabetic mice. J Clin Invest 105, 1537-1545.
3. Jia Y, Zeng ZZ, Markwart SM, Rockwood KF, Ignatoski KM, Ethier SP, and Livant DL (2004). Integrin fibronectin receptors in matrix metalloproteinase-1- dependent invasion by breast cancer and mammary epithelial cells. Cancer Res 64, 8674-8681.
4. Zeng ZZ, Jia Y, Hahn NJ, Markwart SM, Rockwood KF, and Livant DL (2006). Role of focal adhesion kinase and phosphatidylinositol 3′-kinase in integrin fibronectin receptor-mediated, matrix metalloproteinase-1-dependent invasion by metastatic prostate cancer cells. Cancer Res 66, 8091-8099.
5. Garmy-Susini B, Jin H, Zhu Y, Sung RJ, Hwang R, and Varner J (2005). Integrin alpha4beta1-VCAM-1-mediated adhesion between endothelial and mural cells is required for blood vessel maturation. J Clin Invest 115, 1542-1551.
6. Livant DL (2005). Targeting invasion induction as a therapeutic strategy for the treatment of cancer. Curr Cancer Drug Targets 5, 489-503.
7. Maschler S, Wirl G, Spring H, Bredow DV, Sordat I, Beug H, and Reichmann E (2005). Tumor cell invasiveness correlates with changes in integrin expression and localization. Oncogene 24, 2032-2041.
8. Cianfrocca ME, Kimmel KA, Gallo J, Cardoso T, Brown MM, Hudes G, Lewis N, Weiner L, Lam GN, Brown SC, et al. (2006). Phase 1 trial of the antiangiogenic peptide ATN-161 (Ac-PHSCN-NH(2)), a beta integrin antagonist, in patients with solid tumours. Br J Cancer 94, 1621-1626.
9. Khalili P, Arakelian A, Chen G, Plunkett ML, Beck I, Parry GC, Donate F, Shaw DE, Mazar AP, and Rabbani SA (2006). A non-RGD-based integrin binding peptide (ATN-161) blocks breast cancer growth and metastasis in vivo. Mol Cancer Ther 5, 2271-2280.
10. Stoeltzing O, Liu W, Reinmuth N, Fan F, Parry GC, Parikh AA, McCarty MF, Bucana CD, Mazar AP, and Ellis LM (2003). Inhibition of integrin alpha5beta1 function with a small peptide (ATN-161) plus continuous 5-FU infusion reduces colorectal liver metastases and improves survival in mice. Int J Cancer 104, 496-503.
11. van Golen KL, Bao L, Brewer GJ, Pienta KJ, Kamradt JM, Livant DL, and Merajver SD (2002). Suppression of tumor recurrence and metastasis by a combination of the PHSCN sequence and the antiangiogenic compound tetrathiomolybdate in prostate carcinoma. Neoplasia 4, 373-379.
12. Collo G and Pepper MS (1999). Endothelial cell integrin alpha5beta1 expression is modulated by cytokines and during migration in vitro. J Cell Sci 112 (Pt 4), 569-578.
13. Enenstein J, Waleh NS, and Kramer RH (1992). Basic FGF and TGF-beta differentially modulate integrin expression of human microvascular endothelial cells. Exp Cell Res 203, 499-503.
14. Umeda N, Kachi S, Akiyama H, Zahn G, Vossmeyer D, Stragies R, and Campochiaro PA (2006). Suppression and regression of choroidal neovascularization by systemic administration of an alpha5beta1 integrin antagonist. Mol Pharmacol 69, 1820-1828.
15. Milner R and Campbell IL (2002). Developmental regulation of beta1 integrins during angiogenesis in the central nervous system. Mol Cell Neurosci 20, 616-626.
16. Magnussen A, Kasman IM, Norberg S, Baluk P, Murray R, and McDonald DM (2005). Rapid access of antibodies to alpha5beta1 integrin overexpressed on the luminal surface of tumor blood vessels. Cancer Res 65, 2712-2721.
17. Parsons-Wingerter P, Kasman IM, Norberg S, Magnussen A, Zanivan S, Rissone A, Baluk P, Favre CJ, Jeffry U, Murray R, et al. (2005). Uniform overexpression and rapid accessibility of alpha5beta1 integrin on blood vessels in tumors. Am J Pathol 167, 193-211.
18. Livant DL, Linn S, Markwart S, and Shuster J (1995). Invasion of selectively permeable sea urchin embryo basement membranes by metastatic tumor cells, but not by their normal counterparts. Cancer Res 55, 5085-5093.
19. Vila-Carriles WH, Zhou ZH, Bubien JK, Fuller CM, and Benos DJ (2007). Participation of the chaperone Hsc70 in the trafficking and functional expression of ASIC2 in glioma cells. J Biol Chem 282, 34381-34391.
20. Zatyka M, Ricketts C, da Silva Xavier G, Minton J, Fenton S, Hofmann-Thiel S, Rutter GA, and Barrett TG (2008). Sodium-potassium ATPase 1 subunit is a molecular partner of Wolframin, an endoplasmic reticulum protein involved in ER stress. Hum Mol Genet 17, 190-200.
21. Yao H, Dashner EJ, van Golen CM, and van Golen KL (2006). RhoC GTPase is required for PC-3 prostate cancer cell invasion but not motility. Oncogene 25, 2285-2296.
22. Tashiro M, Schafer C, Yao H, Ernst SA, and Williams JA (2001). Arginine induced acute pancreatitis alters the actin cytoskeleton and increases heat shock protein expression in rat pancreatic acinar cells. Gut 49, 241-250.
23. Tsunoda Y, Yao H, Park J, and Owyang C (2003). Cholecystokinin synthesizes and secretes leptin in isolated canine gastric chief cells. Biochem Biophys Res Commun 310, 681-684.
24. Anderson JA, Grabowska AM, and Watson SA (2007). PTHrP increases transcriptional activity of the integrin subunit alpha5. Br J Cancer 96, 1394-1403.
25. Oki N, Matsuo H, Nakago S, Murakoshi H, Laoag-Fernandez JB, and Maruo T (2004). Effects of 3,5,3′-triiodothyronine on the invasive potential and the expression of integrins and matrix metalloproteinases in cultured early placental extravillous trophoblasts. J Clin Endocrinol Metab 89, 5213-5221.
26. Albertin G, Ruggero M, Guidolin D, and Nussdorfer GG (2006). Gene silencing of human RAMP2 mediated by short-interfering RNA. Int J Mol Med 18, 531-535.
27. Han S, Ritzenthaler JD, Sitaraman SV, and Roman J (2006). Fibronectin increases matrix metalloproteinase 9 expression through activation of c-Fos via extracellular-regulated kinase and phosphatidylinositol 3-kinase pathways in human lung carcinoma cells. J Biol Chem 281, 29614-29624.
28. Wang GK, Hu L, Fuller GN, and Zhang W (2006). An interaction between insulin-like growth factor-binding protein 2 (IGFBP2) and integrin alpha5 is essential for IGFBP2-induced cell mobility. J Biol Chem 281, 14085-14091.
29. Albig AR, Neil JR, and Schiemann WP (2006). Fibulins 3 and 5 antagonize tumor angiogenesis in vivo. Cancer Res 66, 2621-2629.
30. Donate F, Juarez JC, Guan X, Shipulina NV, Plunkett ML, Tel-Tsur Z, Shaw DE, Morgan WT, and Mazar AP (2004). Peptides derived from the histidineproline domain of the histidine-proline-rich glycoprotein bind to tropomyosin and have antiangiogenic and antitumor activities. Cancer Res 64, 5812-5817.
31. Malinda KM (2003). In vivo Matrigel migration and angiogenesis assays. Methods Mol Med 78, 329-335.
32. Altroff H, van der Walle CF, Asselin J, Fairless R, Campbell ID, and Mardon HJ (2001). The eighth FIII domain of human fibronectin promotes integrin alpha5beta1 binding via stabilization of the ninth FIII domain. J Biol Chem 276, 38885-38892.
33. Aota S, Nomizu M, and Yamada KM (1994). The short amino acid sequence Pro-His-Ser-Arg-Asn in human fibronectin enhances cell-adhesive function. J Biol Chem 269, 24756-24761.
34. Komoriya A, Green LJ, Mervic M, Yamada SS, Yamada KM, and Humphries MJ (1991). The minimal essential sequence for a major cell type-specific adhesion site (CS1) within the alternatively spliced type III connecting segment domain of fibronectin is leucine-aspartic acid-valine. J Biol Chem 266, 15075-15079.
35. Mettouchi A and Meneguzzi G (2006). Distinct roles of beta1 integrins during angiogenesis. Eur J Cell Biol 85, 243-247.
36. Wayner EA, Carter WG, Piotrowicz RS, and Kunicki TJ (1988). The function of multiple extracellular matrix receptors in mediating cell adhesion to extracellular matrix: preparation of monoclonal antibodies to the fibronectin receptor that specifically inhibit cell adhesion to fibronectin and react with platelet glycoproteins Ic-IIa. J Cell Biol 107, 1881-1891.
37. Huhtala P, Humphries MJ, McCarthy JB, Tremble PM, Werb Z, and Damsky CH (1995). Cooperative signaling by alpha 5 beta 1 and alpha 4 beta 1 integrins regulates metalloproteinase gene expression in fibroblasts adhering to fibronectin. J Cell Biol 129, 867-879.
38. Fisher C, Gilbertson-Beadling S, Powers EA, Petzold G, Poorman R, and Mitchell MA (1994). Interstitial collagenase is required for angiogenesis in vitro. Dev Biol 162, 499-510.
39. Tian Q, Stepaniants SB, Mao M, Weng L, Feetham MC, Doyle MJ, Yi EC, Dai H, Thorsson V, Eng J, et al. (2004). Integrated genomic and proteomic analyses of gene expression in Mammalian cells. Mol Cell Proteomics 3, 960-969.
40. Akhtar N, Dickerson EB, and Auerbach R (2002). The sponge/Matrigel angiogenesis assay. Angiogenesis 5, 75-80.
41. Kibbey MC, Grant DS, and Kleinman HK (1992). Role of the SIKVAV site of laminin in promotion of angiogenesis and tumor growth: an in vivo Matrigel model. J Natl Cancer Inst 84, 1633-1638.
42. 2): observation of a U-shaped dose-response curve in several preclinical models of angiogenesis and tumor growth. Clin Cancer Res 14, 2137-2144.
43. Isaacs JT, Isaacs WB, Feitz WF, and Scheres J (1986). Establishment and characterization of seven Dunning rat prostatic cancer cell lines and their use in developing methods for predicting metastatic abilities of prostatic cancers. Prostate 9, 261-281.
44. Francis SE, Goh KL, Hodivala-Dilke K, Bader BL, Stark M, Davidson D, and Hynes RO (2002). Central roles of alpha5beta1 integrin and fibronectin in vascular development in mouse embryos and embryoid bodies. Arterioscler Thromb Vasc Biol 22, 927-933.
45. Kim S, Bell K, Mousa SA, and Varner JA (2000). Regulation of angiogenesis in vivo by ligation of integrin alpha5beta1 with the central cell-binding domain of fibronectin. Am J Pathol 156, 1345-1362.
46. Kloss CU, Werner A, Klein MA, Shen J, Menuz K, Probst JC, Kreutzberg GW, and Raivich G (1999). Integrin family of cell adhesion molecules in the injured brain: regulation and cellular localization in the normal and regenerating mouse facial motor nucleus. J Comp Neurol 411, 162-178.
47. Roman J and McDonald JA (1992). Expression of fibronectin, the integrin alpha 5, and alpha-smooth muscle actin in heart and lung development. Am J Respir Cell Mol Biol 6, 472-480.
48. Lee MH and Murphy G (2004). Matrix metalloproteinases at a glance. J Cell Sci 117 (Pt 18), 4015-4016.
49. Partridge CR, Hawker JR Jr, and Forough R (2000). Overexpression of a secretory form of FGF-1 promotes MMP-1-mediated endothelial cell migration. J Cell Biochem 78, 487-499.
50. Unemori EN, Ferrara N, Bauer EA, and Amento EP (1992). Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Cell Physiol 153, 557-562.
51. Dougan M and Dranoff G (2008). Inciting inflammation: the RAGE about tumor promotion. J Exp Med 205, 267-270.
52. Gebhardt C, Riehl A, Durchdewald M, Nemeth J, Furstenberger G, Muller-Decker K, Enk A, Arnold B, Bierhaus A, Nawroth PP, et al. (2008). RAGE signaling sustains inflammation and promotes tumor development. J Exp Med 205, 275-285.
53. Kolodgie FD, Narula J, Yuan C, Burke AP, Finn AV, and Virmani R (2007). Elimination of neoangiogenesis for plaque stabilization: is there a role for local drug therapy? J Am Coll Cardiol 49, 2093-2101.
54. H2-dependent endothelial progenitor cell recruitment and angiogenic switch in asthma. J Immunol 178, 6482-6494.